Balaxi Pharma’s 14.5% Stock Jump: A Silver Lining in a Tough Quarter Balaxi Pharmaceuticals posts widened Q4 loss and declining revenue but sees sharp share price surge on bulk deals and market activity. Balaxi Pharma Shares Rally Despite Weak Quarterly … Continue reading Balaxi Pharma’s 14.5% Stock Jump: A Silver Lining in a Tough Quarter